Frank Rimerman Advisors LLC Increases Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Frank Rimerman Advisors LLC boosted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 52,000.0% in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 6,773 shares of the company’s stock after buying an additional 6,760 shares during the quarter. Frank Rimerman Advisors LLC’s holdings in HCA Healthcare were worth $2,176,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Bangor Savings Bank grew its position in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after purchasing an additional 45 shares during the period. MFA Wealth Advisors LLC purchased a new position in HCA Healthcare during the second quarter valued at approximately $27,000. Unique Wealth Strategies LLC purchased a new stake in HCA Healthcare in the 2nd quarter worth approximately $28,000. GPS Wealth Strategies Group LLC increased its holdings in shares of HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock valued at $31,000 after purchasing an additional 71 shares in the last quarter. Finally, LifeSteps Financial Inc. purchased a new stake in HCA Healthcare during the first quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total transaction of $659,327.85. Following the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at approximately $6,303,912.75. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Michael S. Cuffe sold 8,358 shares of HCA Healthcare stock in a transaction on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the completion of the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Kathryn A. Torres sold 1,857 shares of HCA Healthcare stock in a transaction dated Thursday, July 25th. The stock was sold at an average price of $355.05, for a total value of $659,327.85. Following the completion of the transaction, the senior vice president now directly owns 17,755 shares of the company’s stock, valued at $6,303,912.75. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 17,202 shares of company stock worth $6,407,273. Company insiders own 1.60% of the company’s stock.

HCA Healthcare Trading Up 0.3 %

Shares of HCA Healthcare stock opened at $404.66 on Friday. The business’s 50 day moving average is $370.57 and its 200-day moving average is $340.65. The stock has a market cap of $105.99 billion, a P/E ratio of 20.17, a P/E/G ratio of 1.46 and a beta of 1.67. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $405.70.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, July 23rd. The company reported $5.50 EPS for the quarter, beating the consensus estimate of $4.97 by $0.53. The company had revenue of $17.49 billion for the quarter, compared to the consensus estimate of $17.05 billion. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The firm’s revenue for the quarter was up 10.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.29 earnings per share. Equities research analysts predict that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, September 30th. Shareholders of record on Monday, September 16th will be given a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 13.16%.

Analyst Ratings Changes

A number of brokerages have weighed in on HCA. Oppenheimer upped their price objective on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Baird R W raised shares of HCA Healthcare to a “strong-buy” rating in a research report on Thursday, May 30th. Cantor Fitzgerald reiterated an “overweight” rating and set a $392.00 target price on shares of HCA Healthcare in a report on Monday, August 19th. Robert W. Baird initiated coverage on HCA Healthcare in a research report on Thursday, May 30th. They issued an “outperform” rating and a $396.00 price objective on the stock. Finally, UBS Group boosted their target price on shares of HCA Healthcare from $405.00 to $438.00 and gave the stock a “buy” rating in a research report on Wednesday, August 14th. Five research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus price target of $359.89.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.